These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 33315089)
1. SIRT4 is the molecular switch mediating cellular proliferation in colorectal cancer through GLS mediated activation of AKT/GSK3β/CyclinD1 pathway. Cui Y; Bai Y; Yang J; Yao Y; Zhang C; Liu C; Shi J; Li Q; Zhang J; Lu X; Zhang Y Carcinogenesis; 2021 Apr; 42(3):481-492. PubMed ID: 33315089 [TBL] [Abstract][Full Text] [Related]
2. DUOX2 promotes the progression of colorectal cancer cells by regulating the AKT pathway and interacting with RPL3. Zhang X; Han J; Feng L; Zhi L; Jiang D; Yu B; Zhang Z; Gao B; Zhang C; Li M; Zhao L; Wang G Carcinogenesis; 2021 Feb; 42(1):105-117. PubMed ID: 32531052 [TBL] [Abstract][Full Text] [Related]
3. TMEM206 promotes the malignancy of colorectal cancer cells by interacting with AKT and extracellular signal-regulated kinase signaling pathways. Zhao J; Zhu D; Zhang X; Zhang Y; Zhou J; Dong M J Cell Physiol; 2019 Jul; 234(7):10888-10898. PubMed ID: 30417481 [TBL] [Abstract][Full Text] [Related]
4. Overexpression of DJ-1 enhances colorectal cancer cell proliferation through the cyclin-D1/MDM2-p53 signaling pathway. Zhu X; Luo C; Lin K; Bu F; Ye F; Huang C; Luo H; Huang J; Zhu Z Biosci Trends; 2020 May; 14(2):83-95. PubMed ID: 32132307 [TBL] [Abstract][Full Text] [Related]
5. Sirtuin 6 inhibits colon cancer progression by modulating PTEN/AKT signaling. Tian J; Yuan L Biomed Pharmacother; 2018 Oct; 106():109-116. PubMed ID: 29957460 [TBL] [Abstract][Full Text] [Related]
6. SIRT4 Has an Anti-Cancer Role in Cervical Cancer by Inhibiting Glutamine Metabolism Zhang Y; Niu X; Wang Y; Bao S; Jiang P; Dong X Anticancer Res; 2024 Jul; 44(7):2861-2870. PubMed ID: 38925807 [TBL] [Abstract][Full Text] [Related]
7. miR-15a-5p enhances the malignant phenotypes of colorectal cancer cells through the STAT3/TWIST1 and PTEN/AKT signaling pathways by targeting SIRT4. Deng J; Wang H; Liang Y; Zhao L; Li Y; Yan Y; Zhao H; Zhang X; Zou F Cell Signal; 2023 Jan; 101():110517. PubMed ID: 36332797 [TBL] [Abstract][Full Text] [Related]
8. Tumour-suppressive function of SIRT4 in human colorectal cancer. Miyo M; Yamamoto H; Konno M; Colvin H; Nishida N; Koseki J; Kawamoto K; Ogawa H; Hamabe A; Uemura M; Nishimura J; Hata T; Takemasa I; Mizushima T; Doki Y; Mori M; Ishii H Br J Cancer; 2015 Jul; 113(3):492-9. PubMed ID: 26086877 [TBL] [Abstract][Full Text] [Related]
9. High expression of protein phosphatase 4 is associated with the aggressive malignant behavior of colorectal carcinoma. Li X; Liang L; Huang L; Ma X; Li D; Cai S Mol Cancer; 2015 Apr; 14():95. PubMed ID: 25927939 [TBL] [Abstract][Full Text] [Related]
10. PIK3CD induces cell growth and invasion by activating AKT/GSK-3β/β-catenin signaling in colorectal cancer. Chen JS; Huang JQ; Luo B; Dong SH; Wang RC; Jiang ZK; Xie YK; Yi W; Wen GM; Zhong JF Cancer Sci; 2019 Mar; 110(3):997-1011. PubMed ID: 30618098 [TBL] [Abstract][Full Text] [Related]
11. Clinical and therapeutic significance of sirtuin-4 expression in colorectal cancer. Huang G; Cheng J; Yu F; Liu X; Yuan C; Liu C; Chen X; Peng Z Oncol Rep; 2016 May; 35(5):2801-10. PubMed ID: 26986234 [TBL] [Abstract][Full Text] [Related]
12. CSRP2 suppresses colorectal cancer progression Chen L; Long X; Duan S; Liu X; Chen J; Lan J; Liu X; Huang W; Geng J; Zhou J Theranostics; 2020; 10(24):11063-11079. PubMed ID: 33042270 [TBL] [Abstract][Full Text] [Related]
13. SIRT4 suppresses the PI3K/Akt/NF‑κB signaling pathway and attenuates HUVEC injury induced by oxLDL. Tao Y; Yu S; Chao M; Wang Y; Xiong J; Lai H Mol Med Rep; 2019 Jun; 19(6):4973-4979. PubMed ID: 31059091 [TBL] [Abstract][Full Text] [Related]
14. GLS1 promotes proliferation in hepatocellular carcinoma cells via AKT/GSK3β/CyclinD1 pathway. Xi J; Sun Y; Zhang M; Fa Z; Wan Y; Min Z; Xu H; Xu C; Tang J Exp Cell Res; 2019 Aug; 381(1):1-9. PubMed ID: 31054856 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of colorectal cancer tumorigenesis by ursolic acid and doxorubicin is mediated by targeting the Akt signaling pathway and activating the Hippo signaling pathway. Hu D; Meng RY; Nguyen TV; Chai OH; Park BH; Lee JS; Kim SM Mol Med Rep; 2023 Jan; 27(1):. PubMed ID: 36382656 [TBL] [Abstract][Full Text] [Related]
16. Long noncoding RNA SNHG14 accelerates cell proliferation, migration, invasion and suppresses apoptosis in colorectal cancer cells by targeting miR-944/KRAS axis through PI3K/AKT pathway. Pei Q; Liu GS; Li HP; Zhang Y; Xu XC; Gao H; Zhang W; Li T Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9871-9881. PubMed ID: 31799655 [TBL] [Abstract][Full Text] [Related]
17. Mammalian SIRT4 is a tumor suppressor of clear cell renal cell carcinoma by inhibiting cancer proliferation, migration and invasion. Wang C; Piao C; Liu J; Zhang Z; Zhu Y; Kong C Cancer Biomark; 2020; 29(4):453-462. PubMed ID: 32675395 [TBL] [Abstract][Full Text] [Related]
18. RasGRF2 promotes migration and invasion of colorectal cancer cells by modulating expression of MMP9 through Src/Akt/NF-κB pathway. Lu P; Chen J; Yan L; Yang L; Zhang L; Dai J; Hao Z; Bai T; Xi Y; Li Y; Kang Z; Xv J; Sun G; Yang T Cancer Biol Ther; 2019; 20(4):435-443. PubMed ID: 30359168 [TBL] [Abstract][Full Text] [Related]
19. The tumor-suppressor gene LZTS1 suppresses colorectal cancer proliferation through inhibition of the AKT-mTOR signaling pathway. Zhou W; He MR; Jiao HL; He LQ; Deng DL; Cai JJ; Xiao ZY; Ye YP; Ding YQ; Liao WT; Liu SD Cancer Lett; 2015 Apr; 360(1):68-75. PubMed ID: 25667121 [TBL] [Abstract][Full Text] [Related]
20. HIF-1α-dependent miR-424 induction confers cisplatin resistance on bladder cancer cells through down-regulation of pro-apoptotic UNC5B and SIRT4. Yu M; Ozaki T; Sun D; Xing H; Wei B; An J; Yang J; Gao Y; Liu S; Kong C; Zhu Y J Exp Clin Cancer Res; 2020 Jun; 39(1):108. PubMed ID: 32522234 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]